Seven Eight Capital, LP Bausch Health Companies Inc. Transaction History

Seven Eight Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$6.1 - $10.41 $151,090 - $257,845	24,769 New	24,769 $172,000
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $273,164 - $636,611	-21,045 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $397,540 - $671,125	21,045 New	21,045 $630,000
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $2.34 Million - $2.87 Million	-111,953 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$20.52 - $26.45 $2.3 Million - $2.96 Million	111,953 New	111,953 $2.82 Million
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $545,464 - $875,711	-30,922 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$20.64 - $25.67 $638,230 - $793,767	30,922 New	30,922 $794,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.